当前位置:首页 - 行情中心 - 博瑞医药(688166) - 财务分析 - 资产负债表

博瑞医药

(688166)

  

流通市值:266.98亿  总市值:266.98亿
流通股本:4.23亿   总股本:4.23亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金1,395,350,964.06961,064,394.02606,217,317.45739,834,101.15
  应收票据及应收账款385,078,155.12316,637,331.11328,608,558.32266,222,283.98
  其中:应收票据0200,000-561,863.51
        应收账款385,078,155.12316,437,331.11328,608,558.32265,660,420.47
  应收款项融资3,655,460.1613,377,809.95,495,627.6610,582,211.46
  预付款项79,974,154.4762,200,221.4883,595,346.5689,901,721.58
  其他应收款合计3,275,861.49,126,583.595,193,034.57,673,356.77
  存货358,509,898.72364,252,795.45369,390,282.32372,419,753.39
  其他流动资产80,797,968.561,843,039.3568,097,539.7257,294,239.64
  流动资产合计2,306,642,462.431,788,502,174.91,466,597,706.531,543,927,667.97
非流动资产:
  长期应收款7,100,0007,100,0004,100,0004,100,000
  长期股权投资168,099,990.57122,790,639.35133,689,407138,570,966.89
  其他权益工具投资123,170,901.47113,170,901.4793,763,126.4273,763,126.42
  其他非流动金融资产184,913,698.55133,413,698.5593,666,850.0476,207,977.95
  投资性房地产55,963,221.8556,683,844.5357,404,467.2158,125,089.89
  固定资产1,517,817,765.221,548,113,4161,486,735,505.631,463,076,322.57
  在建工程1,244,852,534.161,187,202,917.021,237,886,571.451,235,714,599.62
  使用权资产39,482,088.3717,026,652.4213,643,58617,251,757.58
  无形资产78,385,899.879,529,289.3686,496,659.9386,792,258.77
  开发支出319,988,650.73302,773,742.35268,149,745.42224,490,016.39
  商誉--3,120,1003,120,100
  长期待摊费用34,992,085.7736,412,050.4638,422,268.6939,872,684.96
  递延所得税资产111,350,847.8294,679,078.7180,785,460.4870,466,777.4
  其他非流动资产342,291,729.81337,443,273.39295,608,586.5348,315,232.11
  非流动资产合计4,228,409,414.124,036,339,503.613,893,472,334.773,839,866,910.55
  资产总计6,535,051,876.555,824,841,678.515,360,070,041.35,383,794,578.52
流动负债:
  短期借款68,930,180.55110,108,222.21149,265,996.95168,732,665.76
  交易性金融负债4,385,847.167,070,265193,138.98121,142.81
  应付票据及应付账款144,174,774.54185,894,997.14188,968,432.68202,694,593.27
  其中:应付票据20,000,00019,500,00040,000,00050,000,000
        应付账款124,174,774.54166,394,997.14148,968,432.68152,694,593.27
  合同负债31,727,639.3825,559,585.4845,199,400.9928,821,616.16
  应付职工薪酬38,322,952.6956,171,009.5619,693,265.5218,236,636
  应交税费17,577,696.9522,225,392.198,204,424.745,783,760.55
  其他应付款合计12,528,726.738,689,748.6210,164,42452,899,975.24
  一年内到期的非流动负债659,285,010.87845,206,281.51725,461,980.25661,156,902.04
  其他流动负债14,334,91519,380,694.5719,899,756.8518,555,160.62
  流动负债合计991,267,743.871,280,306,196.281,167,050,820.961,157,002,452.45
非流动负债:
  长期借款1,574,244,673.67730,488,592.621,008,650,834.391,039,837,474.2
  应付债券760,545,457.78657,977,546.33450,128,932.89454,709,579.64
  租赁负债26,003,862.2410,207,868.477,299,521.137,920,825.56
  长期应付款126,137,703.63142,108,311.17126,019,137.3367,000,051.63
  递延收益65,292,574.967,247,469.9269,202,364.9471,157,259.96
  其他非流动负债89,976,415.0490,330,188.63--
  非流动负债合计2,642,200,687.261,698,359,977.141,661,300,790.681,640,625,190.99
  负债合计3,633,468,431.132,978,666,173.422,828,351,611.642,797,627,643.44
所有者权益(或股东权益):
  实收资本(或股本)423,104,454423,103,851423,102,473422,768,244
  其他权益工具61,224,231.3561,227,647.7961,234,285.4562,840,182.63
  资本公积1,076,291,276.041,076,097,485.441,036,377,197.611,094,526,817.77
  减:库存股20,051,308.6120,051,308.6110,009,948.6410,009,948.64
  其他综合收益-85,766,086.11-85,438,838.11-124,695,066.81-124,695,066.81
  盈余公积98,567,037.0398,567,037.0386,060,862.5986,060,862.59
  未分配利润976,954,615.87967,660,900.48975,972,411.34942,825,589.68
  归属于母公司股东权益合计2,530,324,219.572,521,166,775.022,448,042,214.542,474,316,681.22
  少数股东权益371,259,225.85325,008,730.0783,676,215.12111,850,253.86
  股东权益合计2,901,583,445.422,846,175,505.092,531,718,429.662,586,166,935.08
  负债和股东权益合计6,535,051,876.555,824,841,678.515,360,070,041.35,383,794,578.52
公告日期2026-04-302026-03-202025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑